Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06MUA
|
|||
| Former ID |
DNC011655
|
|||
| Drug Name |
N-Hydroxy-4-iodo-benzamide
|
|||
| Synonyms |
N-Hydroxy-4-iodobenzamide; CHEMBL155287; 2593-31-9; p-Iodobenzohydroxamic acid; N-Hydroxy-4-iodo-benzamide; AC1LDBQC; AC1Q7DII; 4-Iodobenzohydroximic acid; N-Hydroxy-4-iodobenzamide #; CTK8A6787; MolPort-005-220-499; HXIKIQLHKIBCOH-UHFFFAOYSA-N; BDBM50015131; ZINC20303936; AKOS008969031; NE46453; MCULE-3184298763; EN300-53710
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C7H6INO2
|
|||
| Canonical SMILES |
C1=CC(=CC=C1C(=O)NO)I
|
|||
| InChI |
1S/C7H6INO2/c8-6-3-1-5(2-4-6)7(10)9-11/h1-4,11H,(H,9,10)
|
|||
| InChIKey |
HXIKIQLHKIBCOH-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Arachidonate 5-lipoxygenase (5-LOX) | Target Info | Inhibitor | [1] |
| BioCyc | Aspirin-triggered lipoxin biosynthesis | |||
| Resolvin D biosynthesis | ||||
| Leukotriene biosynthesis | ||||
| Lipoxin biosynthesis | ||||
| Aspirin triggered resolvin D biosynthesis | ||||
| Aspirin triggered resolvin E biosynthesis | ||||
| KEGG Pathway | Arachidonic acid metabolism | |||
| Metabolic pathways | ||||
| Serotonergic synapse | ||||
| Ovarian steroidogenesis | ||||
| Toxoplasmosis | ||||
| NetPath Pathway | IL4 Signaling Pathway | |||
| Pathwhiz Pathway | Arachidonic Acid Metabolism | |||
| WikiPathways | Vitamin D Receptor Pathway | |||
| Arachidonic acid metabolism | ||||
| Eicosanoid Synthesis | ||||
| Selenium Micronutrient Network | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Hydroxamic acid inhibitors of 5-lipoxygenase: quantitative structure-activity relationships. J Med Chem. 1990 Mar;33(3):992-8. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.